Nemus Bioscience Inc. is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids. These molecules display pleiotropic activity by virtue of selectively binding to two types of cannabinoid receptors (CB1 and CB2 receptors) located throughout multiple organ systems in the body. The Company is developing novel and proprietary classes of product candidates that are designed to improve therapeutic options through enhanced chemical engineering that allow drug candidates to have more predictable bioavailability and pharmacokinetics leading to optimized efficacy and safety.

TypePublic
HQCosta Mesa, US
Founded2012
Size (employees)3 (est)
Websitenemusbioscience.com
Nemus Bioscience was founded in 2012 and is headquartered in Costa Mesa, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Nemus Bioscience Office Locations

Nemus Bioscience has an office in Costa Mesa
Costa Mesa, (HQ)
1100 600 Anton Blvd
Show all (1)
Report incorrect company information

Nemus Bioscience Financials and Metrics

Nemus Bioscience Revenue

Nemus Bioscience's revenue was reported to be $339.93 k in FY, 2013
USD

EBIT (Q2, 2018)

(2.3m)

Cash (30-Jun-2018)

1.9m
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017

Revenue

339.9k

General and administrative expense

28.5k3.7m3.5m3.5m

R&D expense

576.1k939.0k311.3k

Operating expense total

347.2k4.3m4.5m3.9m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

63.4k72.8k71.1k

General and administrative expense

8.6k7.1k9.2k872.6k1.3m744.0k1.1m1.0m775.6k1.3m670.3k673.1k1.2m

R&D expense

37.2k43.4k152.3k135.4k460.0k80.5k92.1k60.7k88.6k25.0k

Operating expense total

64.7k86.3k67.0k909.8k1.4m896.3k1.2m1.5m856.1k1.4m730.9k761.6k1.3m
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017

Cash

52.2k3.2m64.8k260.0k

Accounts Receivable

236.4m

Current Assets

106.1k3.5m279.5k555.8k

PP&E

13.4k9.6k1.4k
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

46.5k50.0k39.2k176.7k601.3k4.3m2.1m831.7k319.9k380.3k108.9k42.0k2.9m1.9m

Current Assets

103.7k87.9k78.6k431.1k785.5k4.5m2.3m1.0m635.2k575.9k445.0k306.1k3.2m2.0m

PP&E

12.0k19.0k16.7k16.0k20.8k16.9k13.0k7.2k4.7k2.6k2.1k5.0k

Total Assets

140.8k122.7k167.6k468.7k820.8k4.5m2.3m1.1m692.1k617.4k484.0k343.0k3.2m2.0m
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017

Net Income

(3.8k)(4.8m)(3.2m)(3.1m)

Depreciation and Amortization

10.9k10.0k14.9k8.0k

Accounts Payable

10.8k(274.1k)149.3k(173.7k)

Cash From Operating Activities

(14.5k)(3.7m)(3.6m)(3.3m)
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

3.6k(10.0k)(2.2k)(910.2k)(3.0m)(4.1m)(1.7m)(1.1m)(2.1m)(1.3m)(2.0m)(2.5m)(8.2m)(10.9m)

Depreciation and Amortization

2.4k4.7k7.9k2.3k4.6k7.3k3.7k7.6k11.5k2.4k4.9k6.8k331.0813.0

Accounts Payable

(2.3k)(1.1k)(9.0k)(21.4k)(113.6k)(267.3k)12.0k57.9k262.0k(47.5k)404.8k715.5k(2.2k)(89.0k)

Cash From Operating Activities

(4.1k)(832.0)7.1k(751.7k)(1.3m)(2.6m)(1.1m)(2.4m)(2.9m)(816.4k)(1.1m)(1.2m)(1.1m)(2.1m)
USDY, 2018

Financial Leverage

-0.2 x
Show all financial metrics
Report incorrect company information

Nemus Bioscience Online and Social Media Presence

Embed Graph
Report incorrect company information

Nemus Bioscience News and Updates

Nemus Bioscience to Present at Investment and Scientific Conferences in December

Long Beach, CA, Nov. 29, 2018 (NewMediaWire) -- Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that CEO and Chief Medical Officer Dr. Brian Murphy will present a cor…

Nemus Bioscience to Present at BIO Investor Forum

LONG BEACH, CA - (NewMediaWire) - October 15, 2018 - Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, announced today that Dr. Brian Murphy, Chief Executive Officer a…

Nemus Bioscience Announces that Emerald Health Sciences has Provided a Credit Facility of up to $20 Million and Adopted an Open Market Share Purchase Program of up to 10 Million Common Shares

Avtar Dhillon, MD, appointed as Executive Chairman of NemusLONG BEACH, CA - (NewMediaWire) - October 08, 2018 - Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that the Compan…

UPDATE: Nemus Bioscience, Inc. Signs Agreement with Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredient for Glaucoma

Long Beach, CA, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, today announced an agreement with Albany Molecular Research Inc. for t…

Nemus Bioscience, Inc. Signs Agreement with Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredient for Glaucoma

Long Beach, Calif. - (NewMediaWire) - August 01, 2018 - Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, today announced an agreement with Albany Molecular Research I…
Report incorrect company information

Nemus Bioscience Company Life and Culture

Report incorrect company information

Nemus Bioscience Frequently Asked Questions

  • When was Nemus Bioscience founded?

    Nemus Bioscience was founded in 2012.

  • How many employees does Nemus Bioscience have?

    Nemus Bioscience has 3 employees.

  • Who are Nemus Bioscience competitors?

    Competitors of Nemus Bioscience include Tilray, Canopy Growth and HERB.

  • Where is Nemus Bioscience headquarters?

    Nemus Bioscience headquarters is located at 1100 600 Anton Blvd, Costa Mesa.

  • Where are Nemus Bioscience offices?

    Nemus Bioscience has an office in Costa Mesa.

  • How many offices does Nemus Bioscience have?

    Nemus Bioscience has 1 office.